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An infectivity assay for MS2 ribonucleic acid (RNA), which uses bacterial sphero-
plasts of an F- strain of Escherichia coli, has an efficiency of 10-5 infected sphero-
plasts per RNA molecule. The characteristics of this assay and the influence of
several parameters are presented. Important variables include the duration of ex-
posure of the cells to lysozyme-ethylenediaminetetraacetic acid, the duration of
exposure of the spheroplast stock to the RNA solutions before dilution, the con-
centration of RNA, and the presence of competing RNA. The growth kinetics of
the virus in the infected spheroplasts and the extent of lysis have also been studied.
This laboratory has used an infectivity assay for
the ribonucleic acid (RNA) of the small bacterio-
phage MS2 in a variety of experiments, either as
a test for the complete genome of the virus or to
quantitate the number ofRNA molecules present.
Initially, the assay developed by Guthrie and
Sinsheimer (9, 10) for the deoxyribonucleic acid
(DNA) of phage 4X174 was used, with the sole
modification that the RNA was in 0.05 M tris-
(hydroxymethyl)aminomethane (Tris) pH 7.0 in-
stead ofpH 8.1 (1, 3). The efficiency of this assay
varies from about 2 X 10-8 to 5 x 10-7 infections
per RNA molecule and is difficult to reproduce.
This efficiency is the same as or slightly better
than the results first reported by other investi-
gators working with phage RNA (4, 11, 12, 14).
In making this comparison, our unit is the RNA
molecule, determined from absorbancy, rather
than the phage plaque former; our viral stocks
usually contain about 20% active plaque formers.
The report of Ginoza and Vessey (Abstr.
FC5, Annual Meeting of the American Bio-
physical Society, 8th, 1964) led us to re-examine
the RNA infectivity assay, and a more efficient
and reproducible procedure was developed. A
brief summary of the modified assay has been
published (15). Recurring questions, however,
lead us to publish the characteristics of this assay
in more detail.
' The results presented here are part of a thesis by
James H. Strauss, Jr., submitted to the California
Institute of Technology in partial fulfillment of the
requirements for the Ph.D. degree.
2 Present address: Department of Biochemistry,
Albert Einstein College of Medicine, Bronx, N.Y.
10461.
MATERIALS AND METHODS
PA, PAM, and 3XD are as described by Guthrie
and Sinsheimer (10), except for an error in the com-
position of PA and PAM media. These should con-
tain 1 g of glucose per liter. Bovine serum albumin
(BSA) is a 30% sterile solution containing 0.1%
NaN3, as a preservative obtained from Armour Phar-
maceutical Co., Kankakee, Ill. Tris chloride buffer
(pH 7.0) is made by neutralization of a 1 M solution of
Sigma Trizma Base with concentrated HCI to pH
7.0, at which time the temperature of the solution is
35 to 37 C.
The assay for bacteriophage MS2 is given in Davis
and Sinsheimer (2), except that bacterial strain, Es-
cherichia coli A19, was often used for seed bacteria.
This strain, which lacks ribonuclease I, and strain
Q13, which lacks both ribonuclease I and polynucleo-
tide phosphorylase, were obtained from R. F. Geste-
land (7).
The bacterial strain routinely used for the prepa-
ration of spheroplast stocks has been Escherichia coli
K-12 strain W6. These F- cells and the spheroplast
stocks prepared from them are resistant to the mature
virus, thus eliminating reinfection during the assay.
All results refer to W6 spheroplast stocks unless
noted otherwise.
Spheroplast stocks have also been prepared from
the Hfr strains C3000, A19, and Q13. As these cells
and the spheroplast stocks prepared from them are
susceptible to the mature virus, reinfection by prog-
eny phage will occur; therefore, such infected sphero-
plasts must either be assayed before reinfection
occurs, or, alternatively, the time of incubation after
infection must be carefully controlled. In the latter
case, the assay is not strictly proportional to the con-
centration of RNA.
Cells to be converted to spheroplasts are grown in
3XD to 3 X 108 to 5 X 108/ml (as observed with a
Petroff-Hausser counter) and collected by centrifuga-
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tion at room temperature. For each 20 ml of original
cell suspension, the following (in milliliters) are added
at room temperature: 1.5 M sucrose, 0.35; 30% BSA,
0.17; lysozyme solution (2 mg/ml in 0.25 M Tris,
pH 8.1), 0.02; and 4% disodium ethylenediamine-
tetraacetic acid (EDTA), 0.04. Addition of EDTA
initiates the "conversion period," and subsequent
addition of Mg++ terminates it. For conversion
periods of 1 min or less, the Mg++ is added as 9.6 ml
of PAM medium. For conversion periods of 1 min
or more, 9.6 ml of PA medium is added immediately
after EDTA, followed by 0.2 ml of 10% MgSO4 after
the desired conversion period. All spheroplast stocks
are routinely chilled in ice water before use.
Infection of the spheroplast stock with MS2 RNA
is initiated by adding 0.4 ml of stock to 0.4 ml of the
RNA suspension. Normally the RNA is in 0.05 M
Tris (pH 7.0), in a 37 C water bath. The "infection
period" is terminated and the "incubation period"
is initiated by dilution of this infection mixture with
3.2 ml of PAM medium to give the "incubation mix-
ture". B-D Cornwall Continuous Pipetting Outfits
(Becton, Dickinson and Co., Rutherford, N.J.) are
used for dispensing both the spheroplast stock and
PAM medium.
The infectivity of the RNA preparation is measured
either by direct assay of the infected spheroplasts,
or by assay of the progeny phage produced. Infected
spheroplasts are assayed after a 10- to 15-min incuba-
tion period, by use of the method of Guthrie and
Sinsheimer (10). The assay based upon production
of progeny phage uses an incubation period of 1.5 to
3 hr. The infected spheroplasts are then lysed either
by freeze-thawing (once), by dilution into distilled
water for 10 min, or by addition of a few drops of
CHCl3 and vigorous mixing; the released phage are
then titered.
The results are expressed as infected spheroplasts
per RNA molecule or as progeny plaque-forming
units (PFU) per RNA molecule. The latter figure can
be related to the former by the average burst size as
measured in single-burst experiments.
Single-burst experiments were performed by use of
RNA at a concentration such that progeny phage were
present in only 10 to 25% of the tubes.
The preparation of MS2 RNA has been described
(16). The concentration of RNA is expressed in
molecules per milliliter, determined from the ab-
sorbancy of the RNA preparation. Tobacco mosaic
virus (TMV) was prepared from infected tobacco
leaves by the method of Simmons, as described in
Friesen and Sinsheimer (6). RNA was isolated from
TMV by the method of Fraenkel-Conrat et al. (5).
Lysates of E. coli C3000, prepared by lysozyme-
EDTA treatment of the cells and subsequent lysis with
a neutral detergent (8), were kindly provided by G.
N. Godson. Ribosomal RNA was prepared by phenol
extraction of ribosomes isolated from these lysates.
RESULTS
Preparation of spheroplast stocks. Short periods
of conversion of cells to spheroplasts consistently
provided more efficient stocks, and the presence
TABLE 1. Effect of the duration of the conversion
period on the efficiency of the spheroplast
stock
PFU/RNA molecule
Expta Conversion _
period(min)-
+BSA -BSA
1 1 1.7 X 10-4 0.28 X 10-4
3 1.6 X 10-4 0.24 X 104
6 1.4 X 10-4 0.27 X 10-4
10 0.6>X10-X 0.17 X 10-4
20 0.6 X 10-4 0.15 X 10-4
2 0.5 1.4 X 10-4 0.16 X 10-4
1 0.6 X 10-4 0.11 X 10-4
a Infection period was 10 min at 35 C, and the
incubation period was 90 min at 35 C.
of BSA improved the measured infectivity of
RNA preparations. The data in Table 1 illustrate
these observations.
When the infection period was shorter than in
Table 1 (see below), the conversion period was
still optimal at about 30 sec. In this case, omission
of the BSA led to a more drastic reduction in
efficiency.
Spheroplast stocks prepared with the short con-
version period contained less than 50% com-
pletely rounded forms by microscopic examina-
tion. Most of the cells were affected by the lyso-
zyme treatment, however, as evidenced by partial
rounding. The efficiency of these stocks was
stable for at least 24 hr in the cold.
The best results were obtained with the Armour
30% solution of BSA; 30% solutions of BSA
made from both Armour and Sigma Fraction V
powder were also tried with much poorer success.
When the cell concentration of W6 is allowed
to go beyond 5 x 108/ml, the resulting sphero-
plast stocks are definitely less efficient.
Spheroplast stocks prepared from the Hfr
strains C3000, A19, and Q13 were about 10% as
efficient as those prepared from the F- strain W6.
Infection and incubation periods. The length of
the infection period is critical. The result of vary-
ing the length of the infection period with several
spheroplast stocks is shown in Fig. 1. The sharp-
ness of the optimum depended in part upon the
concentration of the stock, and less concentrated
stocks provided a broader plateau. The decline in
progeny phage titer as the infection period was
lengthened was a consequence of a loss of in-
fected spheroplasts, for single-burst experiments
indicate that the average burst size was the same
for infection periods of 30 sec and 10 min.
The best results were obtained by mixing equal
volumes of RNA suspension and spheroplast
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FIG. 1. Effect of the duration of the infection period
on the progeny phage titer. Infection and incubation
were at 37 C. The concentrations of the spheroplast
stocks and the lengths of the incubation periods in the
three experiments were: 1.2 X 109/ml, 90 min (0);
8 X 108/ml, 90 min (A); and 5.4 X 1081ml, 3 hr (0).
stock to initiate infection. Large deviations from
equal volumes sharply decreased the infectivity
of MS2 RNA. Maximal production of phage re-
quired dilution of the infection mixture at least
fivefold with PAM medium before incubation;
further dilution was without effect.
The optimal temperature for incubation was
36 to 38 C. Incubation at lower temperatures de-
creased the burst size. The infection period may
be conducted at 30 C or 37 C with equal efficiency
(with proper adjustment in the length of the in-
fection period), as long as the incubation period
is conducted at 37 C.
Maximal phage production required 2.5 to
3 hr of incubation at 37 C. The phage titer was
then stable for at least another 2 hr (Fig. 2).
Tris and phosphate buffers of varying ionic
strength were tested as the RNA solvent. Buffer
concentrations above 0.05 M were sharply inhibi-
tory to the assay. The results with buffer concen-
trations from 0.001 to 0.05 M were somewhat de-
pendent upon the spheroplast stock. Most often
an optimum at 0.005 to 0.01 M was observed with
little difference between Tris and phosphate
buffers. The results of two experiments showing
this effect are given in Table 2.
0 O 50 100 150 200 250"300
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FIG. 2. Growth curve of MS2 in RNA-infected
spheroplasts. MS2 RNA was used at 5 X 101° mole-
cules/ml. Infection was for 30 sec at 37 C. Incubation
was also at 37 C. At intervals, samples were removed
and infective centers were assayed without artificial
lysis of the infected spheroplasts (A), or after lysis
with CHCl3(0).
TABLE 2. Influence of the buffer concentration of
the RNA solvent on progeny PFU produced
PFU/RNA molecule
Expta Buffer concn
Tris Phosphate
1 0.01 4.7 X 10-3 4.7 X 1I0-
0.05 2.6 X 10-3 1.2 X 10-3
0.1 0.7 X 10-3 0.1 X 10-3
0.2 10-6
2 0.001 6.2 X 10-3 6.2 X 103
0.005 9.2 X 10-3 8.5 X 10-3
0.01 10.4 X 103 6.2 X 103
0.05 7.0 X 103 2.4 X 10-
a Infection period was 30 sec at 37 C, and the
incubation period was 3 hr at 37 C.
RNA solvents at three different values of pH
were tested. No difference was found between
0.05 M Tris at pH 7.0 or 8.1; 0.05 M sodium
acetate at pH 5.0 was an order of magnitude less
efficient than 0.05 M Tris at pH 7.0.
The presence of up to 10% of the organic sol-
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vents formamide, dimethylformamide, or di-
methylsulfoxide in the RNA solvent had little
effect on the assay (not more than 30% inhibi-
tion).
Growth of the virus and lysis of the spheroplasts.
A growth curve of MS2 in RNA-infected sphero-
plasts is shown in Fig. 2. By analogy with growth
curves of phage-infected bacteria, the "eclipse
period" is 25 to 30 min. Lysis of some of the in-
fected spheroplasts began 5 to 10 min later; phage
production and lysis continued for about 2 hr.
In this experiment, the infected centers apparently
increased between 5 and 20 min, but more fre-
quently the infected-center count was constant
between 5 and 25 min after infection.
About one-third of the infected W6 sphero-
plasts eventually lysed spontaneously (Fig. 2).
This lysis took place in the incubation tube and
was not produced in the plating procedure. Ex-
periments with A19 spheroplasts, which are in-
fectible by the mature virus, indicate that about
one-third of the infected A19 spheroplasts simi-
larly lysed in the incubation tube. Growth curves
of MS2 in RNA-infected A19 spheroplasts did
not begin to level off until after 3 hr of incuba-
tion; there was then a slower rise in phage titer
for at least another 2 hr. After 5 hr, apparent
burst sizes of 108 were produced, because some
of the infected spheroplasts lyse, leading to mul-
tiple infection cycles. A single-burst experiment
was performed to quantitate the fraction of in-
fected A19 spheroplasts which lyse. In this
100-tube experiment, 75 tubes contained no
phage. Of the 25 tubes which did contain phage,
17 tubes had burst sizes from 35 to 3,800 and an
average burst size of 1,400. The remaining tubes
had apparent burst sizes from 1.6 x 106 to
6 x 109 and an average apparent burst size of
9 X 108. Thus, two-thirds of the bursts had rea-
sonable values for a single burst; in the other
one-third, lysis of the original infected sphero-
plast was clearly followed by subsequent reinfec-
tion cycles.
Comparison of the assayfor infected spheroplasts
and the assay for progeny phage. Plating for in-
fected spheroplasts was one-tenth to one-third as
efficient per infective center, as was the assay for
progeny phage. The number of infected sphero-
plasts may be calculated from the final phage
titer, by use of the burst size. For W6 sphero-
plasts, the burst size was 2,000 in a number of
single-burst experiments. To determine a burst
size for A19 spheroplasts, the concentration of
infective centers was calculated from the fre-
quency of bursts in a single'burst experiment
(assuming a Poisson distribution). This concen-
tration, together with a growth curve of MS2 in
RNA-infected A19 spheroplasts, defines an ap-
parent burst size as a function of the duration of
the incubation period.
The number of infected spheroplasts calculated
in either case from the progeny phage titer was
usually threefold higher than that measured by
direct plating.
The top agar used in the assay for infected
spheroplasts was PAM medium containing BSA
and agar. By analogy with the conditions in liquid
medium, it is probable that only one-third of the
infected spheroplasts lysed on the plate, leading
to the observed lower efficiency.
Effect of RNA concentration on the assay. A
typical dilution curve of MS2 RNA is shown in
Fig. 3. Duplicate points have been included to
illustrate that reproducibility was usually quite
good. Phage production is linear with RNA con-
centration over at least four orders of magnitude.
The dilution curve of MS2 RNA (Fig. 3) becomes
nonlinear in the concentration range of 10"1 to
1012 molecules/ml (or 1010 to 1011 molecules/ml
upon dilution into the incubation mixture as pre-
sented in Fig. 3), and is completely saturated by
1012 molecules/ml. As 0.004 absorbancy units
correspond to 1011 MS2 RNA molecules/ml, the
infection is saturated when the RNA concentra-
tion is in the range 0.004 to 0.02 absorbancy
units/ml.
With the better stocks, about 1 %,? of the
spheroplasts can be infected with saturating
amounts of RNA.
Inhibition of the assay by TMV RNA and E.
coli ribosomal RNA is shown in Fig. 4. Inhibition
began when the competing RNA concentration
was about 0.004 absorbancy units/ml. When the
competing RNA concentration was greater than
0.004 absorbancy units/ml, the inhibition was
RNA MOLECULES/ ML IN INCUBATION TUBE
FIG. 3. Dilution curve of MS2 RNA. Infection was
for 30 sec at 37 C, and incubation was for 90 min at
37 C. The line shown has a slope of1.00 and corresponds
to 1.5 X 102 PFU per RNA molecule.
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FIG. 4. Inhibition of the RNA infectivity assay by
TMV RNA and ribosomal RNA. MS2 RNA at a con-
centration of 1010 molecules/ml was assayed in the
presence of increasing amounts of TMV RNA (0) or
Escherichia coli ribosomal RNA (A). Infection was
for 30 sec at 37 C, and intcubation wasfor 3 hr at 37 C.
linear with increasing concentration in the case
of TMV RNA. This implies a strict competition
between the various RNA for uptake or any other
limiting factor. For E. coli ribosomal RNA, how-
ever, the inhibition goes as the 0.7 power of the
concentration, indicating that MS2 RNA has a
competitive advantage.
The influence of external ribonuclease on the
assay. The release of ribonuclease I into the
medium during conversion of E. coli cells to
spheroplasts has been reported by Neu and
Heppel (13). Semiquantitative measurements of
the amount of ribonuclease in these spheroplast
stocks indicate the presence of activity equivalent
to that of about 15 m,g/ml of pancreatic ribo-
nuclease. Of this amount, roughly one-third is
contributed by ribonuclease contamination of the
commercial BSA.
However, the optima in the lengths of the con-
version period and the infection period are not a
result of this ribonuclease activity. Spheroplast
stocks formed from the strains A19 and Q13,
which lack ribonuclease I, show the same optima.
Furthermore, removal of ribonuclease in the BSA
by treatment with bentonite has little effect on
these optima for spheroplasts of W6, A19, or
Q13 (a slight protection was noted in a 10-min
infection period).
DIscUSSION
The efficiency of the modified assay, by use of
the F- strain W6, has varied from 2 X 102 to
2 x 10- progeny PFU per RNA molecule. This
can be restated as 10- to 10-6 infected sphero-
plasts per RNA molecule. With care, the efficiency
is normally the higher value. Glowacki (personal
communication) has obtained an efficiency of
2 X 10-2 PFU/RNA molecule with this method
for both MS2 RNA and Q,B RNA.
We have found that the presence of BSA stimu-
lates the RNA assay. Knolle and Kaudewitz (12)
and Ginoza and Vessey (Abstr. FC5, Annual
Meeting of the American Biophysical Society,
8th, 1964) found that BSA had no effect. Our
finding that Fraction V BSA will not substitute
for the Armour 30% solution may have some
bearing on this. Also, the more efficient the assay,
the greater the stimulation by BSA.
The optima in the duration of the conversion
period and the infection period for RNA infec-
tion, which are in contrast to observations con-
cerning infection with the DNA of bacteriophage
4X174 (9, 10; unpublished observations), appear
to be related to the metabolic integrity of the cell
and the dynamics of RNA-host interaction. In
the case of 45X DNA, longer periods of lysozyme-
EDTA treatment increase the efficiency of nu-
cleic acid uptake by the spheroplasts. The sphero-
plasts become less efficient for RNA infection
with increased conversion period, presumably
because of increasing structural damage to the
cell which is of greater consequence than the
possibility of increased uptake.
The optimum in the duration of the infection
period means that RNA molecules which have
been adsorbed and are capable of producing
progeny have at least a 90% probability of be-
coming noninfective, unless the mixture is diluted
quickly with PAM medium. OX DNA, however,
is apparently stable under these conditions, and
more infected spheroplasts accrue as the infection
period is lengthened.
These empirical optima, however, provide only
a partial explanation for the 1,000-fold difference
in efficiency of infection with MS2 RNA as com-
pared with 4X DNA. In experiments with both
W6 and A19 spheroplasts, the efficiency of DNA
infection could be improved about 10- to 20-fold
through the use of longer conversion and infec-
tion periods than those optimal for RNA infec-
tion.
Also, the ultimate capacity of the spheroplast
stocks is the same in either case; about 1% of the
cells can be infected with saturating concentra-
tions of 46X DNA (10) or MS2 RNA. Thus, at
present, the difference in efficiency of the two
nucleic acids cannot be explained.
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